|
|
| CP2D6_HUMAN |
CYP2D6 |
Cytochrome P450 2D6 |
6.945e-07 |
1.00
|
| CP1A2_HUMAN |
CYP1A2 |
Cytochrome P450 1A2 |
0.8363 |
1.00
|
| Q95214_RABIT |
ACAT |
Acyl-CoA:cholesterol acyltransferase |
3.364e-119 |
0.43
|
| KCNQ1_HUMAN |
KCNQ1 |
Potassium voltage-gated channel subfamily KQT member 1 |
2.701e-59 |
0.34
|
| CML1_HUMAN |
CMKLR1 |
Chemokine-like receptor 1 |
1.632e-53 |
0.36
|
| FKB1A_RAT |
Fkbp1a |
Peptidyl-prolyl cis-trans isomerase FKBP1A |
1.914e-53 |
0.32
|
| Q8QGU2_CHICK |
FKBP12.6 |
Peptidylprolyl isomerase |
8.283e-48 |
0.30
|
| DCNL1_HUMAN |
DCUN1D1 |
DCN1-like protein 1 |
3.059e-43 |
0.37
|
| PAG_BACAN |
pagA |
Protective antigen |
3.897e-43 |
0.32
|
| Q6Q253_PIG |
5-HT4R |
5-hydroxytryptamine receptor 4 protein |
6.023e-42 |
0.31
|
| ACKR3_HUMAN |
ACKR3 |
Atypical chemokine receptor 3 |
9.56e-39 |
0.35
|
| Q5YLN7_CANLF |
SCN5A |
Voltage-gated sodium channel Nav1.5 cardiac isoform |
1.947e-38 |
0.30
|
| PPCE_PIG |
PREP |
Prolyl endopeptidase |
1.03e-36 |
0.32
|
| MTR1C_XENLA |
mtnr1c |
Melatonin receptor type 1C |
1.179e-34 |
0.32
|
| FKB1A_HUMAN |
FKBP1A |
Peptidyl-prolyl cis-trans isomerase FKBP1A |
1.001e-29 |
0.42
|
| OPRX_MOUSE |
Oprl1 |
Nociceptin receptor |
1.053e-29 |
0.37
|
| SOAT1_RAT |
Soat1 |
Sterol O-acyltransferase 1 |
1.171e-26 |
0.36
|
| PPCE_BOVIN |
PREP |
Prolyl endopeptidase |
3.393e-26 |
0.29
|
| SPHK2_MOUSE |
Sphk2 |
Sphingosine kinase 2 |
3.138e-25 |
0.31
|
| SC6A1_RAT |
Slc6a1 |
Sodium- and chloride-dependent GABA transporter 1 |
2.384e-24 |
0.36
|
| SCN4A_HUMAN |
SCN4A |
Sodium channel protein type 4 subunit alpha |
2.883e-24 |
0.62
|
| KCNQ5_HUMAN |
KCNQ5 |
Potassium voltage-gated channel subfamily KQT member 5 |
7.498e-24 |
0.29
|
| GLUPH_PLAF7 |
|
Bifunctional glucose-6-phosphate 1-dehydrogenase/6-phosphogluconolactonase |
1.069e-23 |
0.29
|
| SC6A1_HUMAN |
SLC6A1 |
Sodium- and chloride-dependent GABA transporter 1 |
1.288e-23 |
0.39
|
| CHLE_MOUSE |
Bche |
Cholinesterase |
1.673e-23 |
0.29
|
| TPP2_RAT |
Tpp2 |
Tripeptidyl-peptidase 2 |
5.888e-22 |
0.34
|
| O96526_LEIMA |
CRK3 |
Cdc2-related kinase |
4.191e-19 |
0.29
|
| CNR2_HUMAN |
CNR2 |
Cannabinoid receptor 2 |
8.797e-19 |
0.40
|
| KCNQ4_HUMAN |
KCNQ4 |
Potassium voltage-gated channel subfamily KQT member 4 |
1.753e-18 |
0.29
|
| DUS22_HUMAN |
DUSP22 |
Dual specificity protein phosphatase 22 |
5.286e-17 |
0.31
|
| KCNQ2_HUMAN |
KCNQ2 |
Potassium voltage-gated channel subfamily KQT member 2 |
1.11e-15 |
0.30
|
| 5HT4R_CAVPO |
HTR4 |
5-hydroxytryptamine receptor 4 |
2.887e-15 |
0.33
|
| PD1L1_HUMAN |
CD274 |
Programmed cell death 1 ligand 1 |
4.996e-15 |
0.32
|
| SGMR2_RAT |
Tmem97 |
Sigma intracellular receptor 2 |
1.021e-14 |
0.35
|
| ACES_MOUSE |
Ache |
Acetylcholinesterase |
2.032e-14 |
0.33
|
| S1PR4_HUMAN |
S1PR4 |
Sphingosine 1-phosphate receptor 4 |
2.098e-14 |
0.34
|
| O77823_PIG |
PDE4A |
Cyclic AMP-specific phosphodiesterase SSPDE4A1A |
6.384e-14 |
0.38
|
| 5HT1A_RAT |
Htr1a |
5-hydroxytryptamine receptor 1A |
3.173e-13 |
0.39
|
| Q9BRH5_HUMAN |
DGAT1 |
DGAT1 protein |
6.344e-13 |
0.29
|
| PPCE_RAT |
Prep |
Prolyl endopeptidase |
1.197e-12 |
0.31
|
| AA2BR_RAT |
Adora2b |
Adenosine receptor A2b |
1.446e-12 |
0.29
|
| DRD2_RAT |
Drd2 |
D(2) dopamine receptor |
1.757e-12 |
0.41
|
| GNAI1_HUMAN |
GNAI1 |
Guanine nucleotide-binding protein G(i) subunit alpha-1 |
4.251e-12 |
0.30
|
| GNAI3_HUMAN |
GNAI3 |
Guanine nucleotide-binding protein G(i) subunit alpha |
4.251e-12 |
0.30
|
| SCN2A_RAT |
Scn2a |
Sodium channel protein type 2 subunit alpha |
1.883e-11 |
0.38
|
| Q98UH1_DANRE |
oprm1 |
Mu opioid receptor-like OR2 |
3.122e-11 |
0.30
|
| HYES_HUMAN |
EPHX2 |
Bifunctional epoxide hydrolase 2 |
4.806e-11 |
0.34
|
| GNAO_HUMAN |
GNAO1 |
Guanine nucleotide-binding protein G(o) subunit alpha |
5.24e-11 |
0.30
|
| NMUR1_HUMAN |
NMUR1 |
Neuromedin-U receptor 1 |
7.435e-11 |
0.32
|
| PPCE_MOUSE |
Prep |
Prolyl endopeptidase |
1.105e-10 |
0.29
|
| OX1R_HUMAN |
HCRTR1 |
Orexin receptor type 1 |
1.217e-10 |
0.36
|
| TRY3_HUMAN |
PRSS3 |
Trypsin-3 |
1.675e-10 |
0.28
|
| CAC1G_HUMAN |
CACNA1G |
Voltage-dependent T-type calcium channel subunit alpha-1G |
1.932e-10 |
0.35
|
| OPRM_RAT |
Oprm1 |
Mu-type opioid receptor |
2.826e-10 |
0.33
|
| NMUR2_HUMAN |
NMUR2 |
Neuromedin-U receptor 2 |
4.212e-10 |
0.32
|
| SC5A1_HUMAN |
SLC5A1 |
Sodium/glucose cotransporter 1 |
5.051e-10 |
0.31
|
| SPHK1_HUMAN |
SPHK1 |
Sphingosine kinase 1 |
1.406e-09 |
0.32
|
| OX2R_HUMAN |
HCRTR2 |
Orexin receptor type 2 |
1.483e-09 |
0.35
|
| LEF_BACAN |
lef |
Lethal factor |
1.507e-09 |
0.32
|
| EBP_CAVPO |
EBP |
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase |
3.26e-09 |
0.31
|
| TS1R2_HUMAN |
TAS1R2 |
Taste receptor type 1 member 2 |
3.618e-09 |
0.31
|
| CNR2_RAT |
Cnr2 |
Cannabinoid receptor 2 |
4.306e-09 |
0.32
|
| SGMR1_RAT |
Sigmar1 |
Sigma non-opioid intracellular receptor 1 |
4.757e-09 |
0.41
|
| NCEH1_HUMAN |
NCEH1 |
Neutral cholesterol ester hydrolase 1 |
5.362e-09 |
0.30
|
| WNT3_HUMAN |
WNT3 |
Proto-oncogene Wnt-3 |
1.361e-08 |
0.29
|
| SGMR1_CAVPO |
SIGMAR1 |
Sigma non-opioid intracellular receptor 1 |
1.42e-08 |
0.35
|
| DRD2_BOVIN |
DRD2 |
D(2) dopamine receptor |
1.721e-08 |
0.35
|
| SC6A3_RAT |
Slc6a3 |
Sodium-dependent dopamine transporter |
1.765e-08 |
0.39
|
| TS1R3_HUMAN |
TAS1R3 |
Taste receptor type 1 member 3 |
2.54e-08 |
0.31
|
| 5HT4R_RAT |
Htr4 |
5-hydroxytryptamine receptor 4 |
3.024e-08 |
0.32
|
| NPBW1_HUMAN |
NPBWR1 |
Neuropeptides B/W receptor type 1 |
3.574e-08 |
0.33
|
| ADA2A_BOVIN |
ADRA2A |
Alpha-2A adrenergic receptor |
4.216e-08 |
0.38
|
| CNR1_HUMAN |
CNR1 |
Cannabinoid receptor 1 |
4.625e-08 |
0.39
|
| P2RX7_HUMAN |
P2RX7 |
P2X purinoceptor 7 |
7.48e-08 |
0.38
|
| CNR1_RAT |
Cnr1 |
Cannabinoid receptor 1 |
8.389e-08 |
0.32
|
| Q865E1_MACMU |
HRH3 |
Histamine receptor H3 |
1.065e-07 |
0.29
|
| REV1_HUMAN |
REV1 |
DNA repair protein REV1 |
1.162e-07 |
0.28
|
| OPRD_RAT |
Oprd1 |
Delta-type opioid receptor |
2.883e-07 |
0.33
|
| SPHK2_HUMAN |
SPHK2 |
Sphingosine kinase 2 |
3.098e-07 |
0.32
|
| CFTR_HUMAN |
CFTR |
Cystic fibrosis transmembrane conductance regulator |
3.266e-07 |
0.31
|
| MMP7_HUMAN |
MMP7 |
Matrilysin |
6.891e-07 |
0.32
|
| PRIO_MESAU |
PRNP |
Major prion protein |
7.167e-07 |
0.32
|
| TERT_HUMAN |
TERT |
Telomerase reverse transcriptase |
8.486e-07 |
0.33
|
| LUXR_ALIFS |
luxR |
Transcriptional activator protein LuxR |
9.067e-07 |
0.28
|
| SC6A1_MOUSE |
Slc6a1 |
Sodium- and chloride-dependent GABA transporter 1 |
1.173e-06 |
0.35
|
| AGP1_YEAST |
AGP1 |
General amino acid permease AGP1 |
1.27e-06 |
0.33
|
| 5HT1F_HUMAN |
HTR1F |
5-hydroxytryptamine receptor 1F |
1.62e-06 |
0.31
|
| PE2R4_HUMAN |
PTGER4 |
Prostaglandin E2 receptor EP4 subtype |
1.827e-06 |
0.40
|
| S1PR5_HUMAN |
S1PR5 |
Sphingosine 1-phosphate receptor 5 |
2.078e-06 |
0.34
|
| PYGL_HUMAN |
PYGL |
Glycogen phosphorylase, liver form |
2.509e-06 |
0.32
|
| ITA4_HUMAN |
ITGA4 |
Integrin alpha-4 |
2.51e-06 |
0.34
|
| PANC_MYCTU |
panC |
Pantothenate synthetase |
2.533e-06 |
0.30
|
| CATK_HUMAN |
CTSK |
Cathepsin K |
2.689e-06 |
0.40
|
| LCK_HUMAN |
LCK |
Tyrosine-protein kinase Lck |
3.134e-06 |
0.36
|
| LDLR_HUMAN |
LDLR |
Low-density lipoprotein receptor |
3.409e-06 |
0.28
|
| PPBI_MOUSE |
Iap |
Intestinal-type alkaline phosphatase |
3.741e-06 |
0.30
|
| CCR5_MACFA |
CCR5 |
C-C chemokine receptor type 5 |
4.596e-06 |
0.29
|
| GLCM_HUMAN |
GBA |
Lysosomal acid glucosylceramidase |
5.98e-06 |
0.33
|
| CPNS1_PIG |
CAPNS1 |
Calpain small subunit 1 |
6.015e-06 |
0.31
|
| 5HT1E_HUMAN |
HTR1E |
5-hydroxytryptamine receptor 1E |
6.575e-06 |
0.32
|
| CP2J2_HUMAN |
CYP2J2 |
Cytochrome P450 2J2 |
7.112e-06 |
0.29
|
| Q4Q5S8_LEIMA |
NMT |
Glycylpeptide N-tetradecanoyltransferase |
8.028e-06 |
0.31
|
| ELOV6_HUMAN |
ELOVL6 |
Elongation of very long chain fatty acids protein 6 |
8.069e-06 |
0.31
|
| SGMR1_HUMAN |
SIGMAR1 |
Sigma non-opioid intracellular receptor 1 |
8.092e-06 |
0.36
|
| CCR5_HUMAN |
CCR5 |
C-C chemokine receptor type 5 |
8.855e-06 |
0.33
|
| XIAP_HUMAN |
XIAP |
E3 ubiquitin-protein ligase XIAP |
9.479e-06 |
0.34
|